ARHGAP42 and hypertensive disorder: Specifically, we showed that GRAF3-deficient mice exhibit significant hypertension and increased pressor responses to Angiotensin II and endothelin 1; an effect that can be prevented by treatment with the Rho kinase inhibitor Y-27632 [18].